Cite
HARVARD Citation
McCoy, J. et al. (2021). 5‐alpha‐reductase inhibitors are associated with reduced frequency of COVID‐19 symptoms in males with androgenetic alopecia. Journal of the European Academy of Dermatology and Venereology. pp. e243-e246. [Online].